Literature DB >> 11396533

Gastro-oesophageal reflux and duodenogastric reflux before and after eradication in Helicobacter pylori gastritis.

D K Manifold1, A Anggiansah, I Rowe, J D Sanderson, C N Chinyama, W J Owen.   

Abstract

OBJECTIVE: Helicobacter pylori and duodenogastric reflux (DGR) are both associated with chronic gastritis, peptic ulcer and gastric cancer. The nature of their interrelationship remains unclear. H. pylori eradication has also been reported to result in new or worsening acid gastro-oesophageal reflux (GOR). The aim of this study was to investigate the relationship between GOR, DGR and H. pylori infection.
METHOD: 25 patients with H. pylori gastritis underwent ambulatory 24-hour oesophageal and gastric pHmetry and gastric bilirubin monitoring before and 12 weeks after H. pylori eradication, confirmed by 14C urea breath testing (UBT). Ten healthy subjects served as a control group.
RESULTS: There were no differences between patient and control groups for gastric alkaline exposure or gastric bilirubin exposure (P> 0.25 in all categories). Oesophageal acid reflux was higher in the study group (P< 0.02). No differences were detected in oesophageal acid reflux, gastric alkaline exposure, or gastric bilirubin exposure (P = 0.35, 0.18 and 0.11, respectively) before and after eradication.
CONCLUSIONS: Acid GOR is not increased by H. pylori eradication. DGR in patients with H. pylori gastritis is similar to that in healthy, non-infected subjects. H. pylori eradication produces no change in GOR or DGR. In patients with chronic gastritis, H. pylori infection and DGR appear to be independent of each other.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11396533     DOI: 10.1097/00042737-200105000-00012

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  7 in total

Review 1.  The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.

Authors:  P Malfertheiner; U Peitz
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

2.  Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole.

Authors:  José L Calleja; Manuel Suarez; Alberto Herreros De Tejada; Angel Navarro
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

3.  Rabeprazole combined with hydrotalcite is effective for patients with bile reflux gastritis after cholecystectomy.

Authors:  Huimin Chen; Xiaobo Li; Zhizheng Ge; Yunjie Gao; Xiaoyu Chen; Yun Cui
Journal:  Can J Gastroenterol       Date:  2010-03       Impact factor: 3.522

4.  Effect of Helicobacter pylori eradication on the treatment of gastro-oesophageal reflux disease.

Authors:  J E Richter
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

5.  Helicobacter pylori eradication does not exacerbate gastro-oesophageal reflux disease.

Authors:  P Malfertheiner
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

6.  Patients with established gastro-esophageal reflux disease might benefit from Helicobacter pylori eradication.

Authors:  John M Moschos; George Kouklakis; Stergios Vradelis; Petros Zezos; Michael Pitiakoudis; Dimitrios Chatzopoulos; Christos Zavos; Jannis Kountouras
Journal:  Ann Gastroenterol       Date:  2014

Review 7.  Bile Reflux Gastritis: Insights into Pathogenesis, Relevant Factors, Carcinomatous Risk, Diagnosis, and Management.

Authors:  Xiaolan Shi; Zijiao Chen; Yi Yang; Su Yan
Journal:  Gastroenterol Res Pract       Date:  2022-09-12       Impact factor: 1.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.